Sort   by:  
 Page size 
UnknownRandomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer.
Not available
S-EPMC5320944 | biostudies-literature
UnknownAn integrated model for Gpr124 function in Wnt7a/b signaling among vertebrates.
Not available
S-EPMC9171404 | biostudies-literature
UnknownNivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Not available
S-EPMC6075826 | biostudies-literature
TranscriptomicsPluripotent Stem Cells Escape From Senescence-Associated DNA Methylation Changes [Illumina]
Pluripotent stem cells evade replicative senescence, whereas other primary cells lose their proliferation and differentiation potential after a limited number of cell divisions M-bM-^@M-^S and this is accompanied by specific senescence-associated DNA methylation (SA-DNAm) changes. Here, we investiga...
ORGANISM(S): Homo sapiens 
2012-09-24 | E-GEOD-37066 | biostudies-arrayexpress
UnknownPhase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Not available
S-EPMC5562171 | biostudies-literature
UnknownDesign and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography.
Not available
S-EPMC9708322 | biostudies-literature
ProteomicsAn organ-specific angiogenic control mechanism for endothelial tailoring.
Each organ of the human body requires locally-adapted blood vessels1–3. The gain of such organotypic vessel specializations is often deemed molecularly unrelated to the process of organ vascularization. Opposing this model, we reveal a molecular mechanism for brain-specific angiogenesis that operate...
ORGANISM(S): Homo sapiens (Human) 
2024-02-08 | PXD042613 | Pride
Angiogenesis  tip cell angiodiversity  wnt/β-catenin signaling  blood-brain barrier  bbb  mmp25  col4a5  col4a6  pial fibroblast  gpr124  reck  wnt7a 
TranscriptomicsPluripotent Stem Cells Escape From Senescence-Associated DNA Methylation Changes
This SuperSeries is composed of the following subset Series: GSE37065: Long-term culture associated gene expression changes in MSC [Affymetrix] GSE37066: Pluripotent Stem Cells Escape From Senescence-Associated DNA Methylation Changes [Illumina] GSE38806: Gene expression profiles of induced pluripot...
ORGANISM(S): Homo sapiens 
2012-09-24 | E-GEOD-37067 | biostudies-arrayexpress
UnknownFirst-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.
Not available
S-EPMC8493593 | biostudies-literature
UnknownTucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.
Not available
S-EPMC11922774 | biostudies-literature
Sort   by:  
 Page size